The legal scrutiny targets potential violations of the Investment Company Act, specifically regarding how Blue Owl managed its asset valuations. According to Ademi LLP, the company’s internal financial reporting may have misrepresented business operations and growth prospects to shareholders. By allegedly assigning artificially high values to certain assets, the firm is suspected of inflating its fee structures at the expense of investors.
Ademi LLP is currently soliciting information from shareholders as it evaluates the strength of these claims. The investigation remains in its early stages, and the law firm has invited stakeholders to participate in the ongoing review process without upfront costs or obligations. This inquiry highlights potential governance risks for the company, which trades under the ticker symbol OTF on the New York Stock Exchange.




Comments (0)
No comments yet. Be the first!